TNF PHARMACEUTICALS INC (TNFA) Stock Price, Quote, News and Overview
NASDAQ:TNFA - Nasdaq - US62856X2018 - Common Stock - Currency: USD
TNFA Quote, Performance and Key Statistics
0.0968
0 (-1.63%)
The current stock price of TNFA is 0.0968 USD. In the past month the price decreased by -11.19%. In the past year, price decreased by -94.47%.
TNFA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 38.74 | 592.95B | ||
| JNJ | JOHNSON & JOHNSON | 17.33 | 417.44B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 16.57 | 228.04B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 12.96 | 226.97B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.2 | 226.19B | ||
| MRK | MERCK & CO. INC. | 10.48 | 202.62B | ||
| PFE | PFIZER INC | 7.25 | 139.75B | ||
| SNY | SANOFI-ADR | 10.66 | 114.95B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.83 | 93.51B | ||
| GSK | GSK PLC-SPON ADR | 8.34 | 76.27B | ||
| ZTS | ZOETIS INC | 23.69 | 65.60B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 49.79 | 45.60B |
Related stock screener links
About TNFA
Company Profile
TNF Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company that engages in the development of drug products to extend healthy lifespan. The company is headquartered in New York City, New York and currently employs 2 full-time employees. The company went IPO on 2008-07-24. The firm is focused on developing two novel therapeutic platforms that treat the causes of disease rather than only addressing the symptoms. Isomyosamine is a drug platform based on a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. Isomyosamine is being developed to treat diseases and disorders marked by acute or chronic inflammation. Isomyosamine works by regulating the release of numerous pro-inflammatory cytokines. The Company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction and epilepsy. Supera-CBD is a novel synthetic derivative of cannabidiol (CBD) and is being developed to address and improve upon the CBD market, which includes both Food and Drug Administration (FDA) approved drugs and CBD products not regulated as drugs.
Company Info
TNF PHARMACEUTICALS INC
1185 Avenue Of The Americas, Suite 249
New York City NEW YORK US
Employees: 2
Phone: 18568488698
TNF PHARMACEUTICALS INC / TNFA FAQ
What is the stock price of TNF PHARMACEUTICALS INC today?
The current stock price of TNFA is 0.0968 USD. The price decreased by -1.63% in the last trading session.
What is the ticker symbol for TNF PHARMACEUTICALS INC stock?
The exchange symbol of TNF PHARMACEUTICALS INC is TNFA and it is listed on the Nasdaq exchange.
On which exchange is TNFA stock listed?
TNFA stock is listed on the Nasdaq exchange.
What is TNF PHARMACEUTICALS INC worth?
TNF PHARMACEUTICALS INC (TNFA) has a market capitalization of 1.37M USD. This makes TNFA a Nano Cap stock.
How many employees does TNF PHARMACEUTICALS INC have?
TNF PHARMACEUTICALS INC (TNFA) currently has 2 employees.
What are the support and resistance levels for TNF PHARMACEUTICALS INC (TNFA) stock?
TNF PHARMACEUTICALS INC (TNFA) has a resistance level at 0.11. Check the full technical report for a detailed analysis of TNFA support and resistance levels.
Should I buy TNF PHARMACEUTICALS INC (TNFA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of TNFA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of TNFA, evaluating the profitability, health, valuation and growth aspects
- TNF PHARMACEUTICALS INC (TNFA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- TNF PHARMACEUTICALS INC (TNFA) Sales and EPS estimates to see what analysts future expectations are.
- TNF PHARMACEUTICALS INC (TNFA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- TNF PHARMACEUTICALS INC (TNFA) Insider and Institutional Ownership to learn about the owners and their transactions.
- TNF PHARMACEUTICALS INC (TNFA) Stock Chart to make your own analysis
- TNF PHARMACEUTICALS INC (TNFA) Latest news and press-releases to stay up to date.
Does TNF PHARMACEUTICALS INC (TNFA) stock pay dividends?
TNFA does not pay a dividend.
When does TNF PHARMACEUTICALS INC (TNFA) report earnings?
TNF PHARMACEUTICALS INC (TNFA) will report earnings on 2025-08-18.
What is the Short Interest ratio of TNF PHARMACEUTICALS INC (TNFA) stock?
The outstanding short interest for TNF PHARMACEUTICALS INC (TNFA) is 18.51% of its float. Check the ownership tab for more information on the TNFA short interest.
TNFA Technical Analysis
TNFA Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
TNFA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to TNFA. The Buy consensus is the average rating of analysts ratings from 7 analysts.